"metastatic lung tumor" trang 3 - tải miễn phí từ tailieunhanh
Complete response to nivolumab in Kirsten rat sarcoma virus oncogene KRAS-G12C mutant metastatic lung adenocarcinoma: A case report

Complete response to nivolumab in Kirsten rat sarcoma virus oncogene KRAS-G12C mutant metastatic lung adenocarcinoma: A case report
6    1    1
Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: A real-world evidence survey

Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: A real-world evidence survey
20    1    1
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: A phase Ib study

Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: A phase Ib study
13    5    1
Identification of hub genes and pathways in lung metastatic colorectal cancer

Identification of hub genes and pathways in lung metastatic colorectal cancer
17    2    1
Improved uptake and survival with systemic treatments for metastatic non-small cell lung cancer: Younger versus older adults

Improved uptake and survival with systemic treatments for metastatic non-small cell lung cancer: Younger versus older adults
11    4    1
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling

Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling
10    1    1
báo cáo hóa học:

báo cáo hóa học:" Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer"
8    36    0
Báo cáo khoa học: Epidermal growth factor receptor-regulated miR-125a-5p – a metastatic inhibitor of lung cancer

Báo cáo khoa học: Epidermal growth factor receptor-regulated miR-125a-5p – a metastatic inhibitor of lung cancer
8    54    0
Pulmonary and cardiovascular radiology with thoracic imaging (Third edition): Part 1

Pulmonary and cardiovascular radiology with thoracic imaging (Third edition): Part 1
1758    55    0
An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion

An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion
8    92    0
Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: A systematic review and secondary analysis of trials

Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: A systematic review and secondary analysis of trials
17    86    0
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: A multicentre, randomised controlled openlabel phase II trial

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: A multicentre, randomised controlled openlabel phase II trial
10    34    1
The Yin/Yan of CCL2: A minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo

The Yin/Yan of CCL2: A minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo
15    55    1
Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics

Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics
12    26    1
SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer

SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer
7    27    1
The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ

The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ
7    45    1
Stage and tissue-specific prognostic impact of miR-182 in NSCLC

Stage and tissue-specific prognostic impact of miR-182 in NSCLC
10    32    1
Long-term outcome and relapse patterns in Ewing sarcoma patients with extensive lung/ pleural metastases after a complete response to systemic therapy

Long-term outcome and relapse patterns in Ewing sarcoma patients with extensive lung/ pleural metastases after a complete response to systemic therapy
8    19    1
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer

A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer
15    8    1
Complete heart block ensuing from a metastatic small cell carcinoma: A case report

Complete heart block ensuing from a metastatic small cell carcinoma: A case report
5    11    1